Oral contraceptives and risk of systemic lupus erythematosus

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1254, 2009-01, pp. : 2-2

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of systemic lupus erythematosus

By Francis Lisa Perl Andras

Expert Opinion on Pharmacotherapy, Vol. 10, Iss. 9, 2009-06 ,pp. : 1481-1494

Informa Healthcare

Access to resources Recommend Favorite

Belimumab: In Systemic Lupus Erythematosus

By Burness Celeste B. McCormack Paul L.

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2435-2444

Adis International

Access to resources Recommend Favorite

Neuropsychiatric Systemic Lupus Erythematosus

Current Neuropharmacology, Vol. 9, Iss. 3, 2011-09 ,pp. : 449-457

Bentham Science Publishers

Access to resources Recommend Favorite

Risk:benefit ratio of nonsteroidal anti-inflammatory drugs in systemic lupus erythematosus

By Horizon Arash A Wallace Daniel J

Expert Opinion on Drug Safety, Vol. 3, Iss. 4, 2004-07 ,pp. : 273-278

Informa Healthcare

Access to resources Recommend Favorite

Dehydroepiandrosterone for the treatment of systemic lupus erythematosus

By van Vollenhoven Ronald F

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 1, 2002-01 ,pp. : 23-31

Informa Healthcare

Access to resources Recommend Favorite